CCL2/CCR2 axis | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,545 results for “CCL2/CCR2 axis”

CCL2/CCR2 Pathway Identified as Key Driver of Aggression in Double-Expressor DLBCL

Targeting Neuroinflammation in Spinal Cord Injury: From Inflammatory Mechanisms to Pharmacological Interventions

Tumor-Associated Macrophages Emerge as Central Drivers of Gastric Cancer Peritoneal Metastasis and Immunotherapy Resistance

Thykamine™ Shows Promising Anti-Fibrotic Effects Through Significant Gene Expression Changes in Preclinical Study

Histone Modifications Drive Tumor-Associated Macrophage Polarization in Cancer Immunotherapy

Gut-Brain Axis Emerges as Key Pathway in Parkinson's Disease Pathogenesis

JAK-STAT1-MED15 Axis Drives Melanocyte Dysfunction in Vitiligo, Study Reveals

Chronic Stress Drives NK-Cell Exhaustion in Cold Tumors via GDF15–AhR Axis

PRMT5 Inhibition Sensitizes B-Cell Lymphoma to Ferroptosis via ATF5-SLC7A11 Axis

Gut Microbiota Emerges as Key Therapeutic Target for Osteoporosis Through Novel Gut-Bone Axis

Page 1 of 35